Who makes Modified Jessner's solution?

Modified Jessner's solution is developed by Assiut University.

What development phase is Modified Jessner's solution in?

Modified Jessner's solution is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Modified Jessner's solution

Assiut University · FDA-approved active Small molecule Quality 2/100

Modified Jessner's solution, marketed by Assiut University, holds a niche position in the dermatological market. The key composition patent expires in 2028, providing a period of exclusivity that supports current market presence. The primary risk is the lack of clear revenue data and key trial results, which may limit investor confidence and market expansion.

At a glance

Generic name	Modified Jessner's solution
Also known as	Combined peel
Sponsor	Assiut University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Modified Jessner's Solution With Trichloroacetic Acid Versus Glycolic Acid With Trichloroacetic Acid (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Modified Jessner's solution CI brief — competitive landscape report
Modified Jessner's solution updates RSS · CI watch RSS
Assiut University portfolio CI